Baidu
map
INT IMMUNOPHARMACOL 润色咨询

INTERNATIONAL IMMUNOPHARMACOLOGY

出版年份：2001 年文章数：5633 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.7% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-04-12 ms5000001369677749 来自江苏省

    一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的

    16

    展开16条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-06-20 ms9000000167770666 来自贵州省

    3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊

    5

    展开5条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-07-09 ms3000000100347447 来自山东省

    偏重的研究方向：中药单体
    经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-07-08 ms2000001344459841 来自天津

    审稿速度:1.0 | 投稿命中率:75.0
    偏重的研究方向：药理;炎症
    经验分享：效率很高，研究工作量大的话非常快
    5.31投稿
    6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。
    6.24修回
    6.30接收
    7.1proof
    7.5proof回
    7.6online
    7.8pubmed可查到

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-03-28 ms1000001286002339 来自四川省

    偏重的研究方向：免疫;炎症
    经验分享：记录状态：
    2024.03.15提交手稿
    2024.03.18With Editor
    发过一封催稿邮件没有回复

    2

    展开2条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2023-09-06 ms6000001433347086 来自贵州省

    想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？

    3

    展开3条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-06-13 ms6000000248938361 来自浙江省

    under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！

    6

    展开6条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2023-09-27 ms8000001070008739 来自上海

    9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……

    9

    展开9条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-06-21 哎呀哎呀哎呀 来自广东省

    请问大家，大修后提交一般会有几个审稿人呀

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2198162, encodeId=086021981629b, content=一篇综述，2.28投稿，3.22小修，4.10接收，速度真挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad068572152, createdName=ms5000001369677749, createdTime=Fri Apr 12 15:47:28 CST 2024, time=2024-04-12, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2210851, encodeId=4957221085156, content=3.26邀请了6个审稿人，只有1个接收审稿，到今天为止，快三个月了，编辑再也没有邀请新的审稿人，要不要撤稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=3, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2448342932, createdName=ms9000000167770666, createdTime=Thu Jun 20 17:31:54 CST 2024, time=2024-06-20, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2214103, encodeId=56c4221410368, content=偏重的研究方向：中药单体<br>经验分享：想问一下大家，这个杂志的WB实验需要提交三次结果吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=af7f8719856, createdName=ms3000000100347447, createdTime=Tue Jul 09 16:55:13 CST 2024, time=2024-07-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2214001, encodeId=90722214001b2, content=审稿速度:1.0 | 投稿命中率:75.0<br>偏重的研究方向：药理;炎症<br>经验分享：效率很高，研究工作量大的话非常快<br>5.31投稿<br>6.15小修--写的是major，实为小修，因为就给了2周时间--2个审稿人，1个提了2个问题，1个提了4个问题，都不是很尖锐。<br>6.24修回<br>6.30接收<br>7.1proof<br>7.5proof回<br>7.6online<br>7.8pubmed可查到, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae76172679, createdName=ms2000001344459841, createdTime=Mon Jul 08 23:15:24 CST 2024, time=2024-07-08, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2195848, encodeId=f8252195848d7, content=偏重的研究方向：免疫;炎症<br>经验分享：记录状态：<br>2024.03.15提交手稿<br>2024.03.18With Editor<br>发过一封催稿邮件没有回复, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5b129030545, createdName=ms1000001286002339, createdTime=Thu Mar 28 11:06:15 CST 2024, time=2024-03-28, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2156410, encodeId=9566215641069, content=想问下友友们，杂志官网写的综述要提前发邮件问编辑，编辑想收这种题材的才可以投嘛？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2eef8398541, createdName=ms6000001433347086, createdTime=Wed Sep 06 16:58:55 CST 2023, time=2023-09-06, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2209668, encodeId=2c952209668b1, content=under review 一周多了，邀请了6个审稿人，但都没有接受审稿的，这咋办呀，还等着毕业。大家遇到没有审稿人接受审稿的情况，大家都是怎么办的呀？请教一下！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bbea5461588, createdName=ms6000000248938361, createdTime=Thu Jun 13 13:38:09 CST 2024, time=2024-06-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159939, encodeId=cf6b215993935, content=9.22投稿，9.24 under review，邀请了9个审稿人，到现在了都没人接……好焦虑……大家都多久才有审稿人接单的……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1fd58097633, createdName=ms8000001070008739, createdTime=Wed Sep 27 01:50:27 CST 2023, time=2023-09-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2210923, encodeId=25cc2210923f6, content=请问大家，大修后提交一般会有几个审稿人呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b248377448, createdName=哎呀哎呀哎呀, createdTime=Fri Jun 21 05:58:51 CST 2024, time=2024-06-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2210805, encodeId=92b92210805fe, content=2023影响因子4.8，扎心了 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/202401/3d5f529618174415816cb5d11ffb639b.jpg, createdBy=d6be2356922, createdName=corgi_anan, createdTime=Thu Jun 20 14:09:24 CST 2024, time=2024-06-20, status=1, ipAttribution=)]
    2024-06-20 corgi_anan

    2023影响因子4.8，扎心了

    0

共500条页码: 1/50页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map